IL47634A0 - Pharmaceutical skin permeating preparations - Google Patents
Pharmaceutical skin permeating preparationsInfo
- Publication number
- IL47634A0 IL47634A0 IL47634A IL4763475A IL47634A0 IL 47634 A0 IL47634 A0 IL 47634A0 IL 47634 A IL47634 A IL 47634A IL 4763475 A IL4763475 A IL 4763475A IL 47634 A0 IL47634 A0 IL 47634A0
- Authority
- IL
- Israel
- Prior art keywords
- preparations
- pharmaceutical skin
- skin permeating
- permeating
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH931274 | 1974-07-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL47634A0 true IL47634A0 (en) | 1975-10-15 |
IL47634A IL47634A (en) | 1978-07-31 |
Family
ID=4350618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL47634A IL47634A (en) | 1974-07-05 | 1975-07-03 | Pharmaceutical skin permeating preparations |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5132724A (en) |
AU (1) | AU8280175A (en) |
BE (1) | BE831042A (en) |
DE (1) | DE2528516A1 (en) |
ES (1) | ES439113A1 (en) |
FR (1) | FR2276832A1 (en) |
GB (1) | GB1518683A (en) |
HU (1) | HU170215B (en) |
IL (1) | IL47634A (en) |
NL (1) | NL7507798A (en) |
NZ (1) | NZ178011A (en) |
SE (1) | SE7507414L (en) |
YU (1) | YU170475A (en) |
ZA (1) | ZA754304B (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54163810A (en) * | 1978-06-14 | 1979-12-26 | Mundipharma Ag | Gel composition for local coating |
JPS56159310A (en) * | 1980-05-14 | 1981-12-08 | Showa Denko Kk | Preparation of monofilament having high strength and knot strength |
FR2483235A1 (en) * | 1980-05-28 | 1981-12-04 | Fabre Sa Pierre | TOPICAL COMPOSITIONS CONTAINING RYE AND VINCA ROSEA ERGOT ALKALOIDS FOR THE TREATMENT OF HYPERSEBORRHOES |
JPS59216825A (en) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | External drug for transcutaneous absorption |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
JPS6013720A (en) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator |
US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
JPH0735331B2 (en) * | 1986-01-16 | 1995-04-19 | 久光製薬株式会社 | External gel formulation |
JPH0735332B2 (en) * | 1986-02-25 | 1995-04-19 | 久光製薬株式会社 | Cream formulation for external use |
JPH0759519B2 (en) * | 1987-02-23 | 1995-06-28 | 株式会社資生堂 | Transdermal absorption enhancer and external preparation for skin containing the same |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
DE3710216A1 (en) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS |
JPH0720866B2 (en) * | 1987-05-15 | 1995-03-08 | 三生製薬株式会社 | Transdermal preparation containing eperisone or tolperisone or their salts |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
CH679119A5 (en) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
GB2230444B (en) * | 1989-04-19 | 1993-12-08 | Ritchie Swanson John | Therapeutic compositions. |
US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
DE69129110T2 (en) * | 1990-05-10 | 1998-12-10 | Bechgaard Int Res | PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLE AND N-ETHYLENE GLYCOL |
IL98747A0 (en) * | 1991-07-05 | 1992-07-15 | Yissum Res Dev Co | Ophthalmic compositions |
ATE212827T1 (en) * | 1993-11-12 | 2002-02-15 | Procter & Gamble | DEFLAVORING COMPOSITION OF SALICYLIC ACID AND ZWITTERIONIC COMPOUNDS |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
US6096326A (en) * | 1997-08-15 | 2000-08-01 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
CN1232244C (en) † | 1999-02-08 | 2005-12-21 | 阿尔萨公司 | Stable non-aqueous single phase viscons vehicles and formulations utilizing such vehicles |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
DK2020990T3 (en) | 2006-05-30 | 2010-12-13 | Intarcia Therapeutics Inc | An internal channel flow modulator for a two-part osmotic feeding system |
ES2398126T3 (en) | 2006-08-09 | 2013-03-13 | Intarcia Therapeutics, Inc | Osmotic release systems and piston units |
RU2440097C2 (en) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it |
JP5333972B2 (en) * | 2007-11-22 | 2013-11-06 | 株式会社 メドレックス | External preparation composition containing fatty acid ionic liquid as active ingredient |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
EP3735944A1 (en) | 2009-09-28 | 2020-11-11 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
JP2012020991A (en) | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | Transdermal absorption promoter, and external skin formulation thereof |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JP5820207B2 (en) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | Transdermal absorption enhancing composition and patch preparation |
JP5820206B2 (en) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | Transdermal absorption enhancing composition and patch preparation |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
EP3213769A4 (en) | 2014-10-30 | 2018-02-21 | Asahi Kasei Kabushiki Kaisha | Transdermal-absorption-promoter and transdermal-absorption-promoting supplement |
JP6993235B2 (en) | 2015-06-03 | 2022-01-13 | インターシア セラピューティクス,インコーポレイティド | Implant installation and removal system |
TWI754643B (en) | 2016-05-16 | 2022-02-11 | 美商因塔希亞治療公司 | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
KR20190104039A (en) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Methods Including Continuous Administration of GLP-1 Receptor Agonists and Co-administration of Drugs |
-
1975
- 1975-06-26 DE DE19752528516 patent/DE2528516A1/en active Pending
- 1975-06-27 SE SE7507414A patent/SE7507414L/en unknown
- 1975-07-01 NL NL7507798A patent/NL7507798A/en unknown
- 1975-07-02 YU YU01704/75A patent/YU170475A/en unknown
- 1975-07-03 NZ NZ178011A patent/NZ178011A/en unknown
- 1975-07-03 IL IL47634A patent/IL47634A/en unknown
- 1975-07-03 ES ES439113A patent/ES439113A1/en not_active Expired
- 1975-07-03 FR FR7520946A patent/FR2276832A1/en active Granted
- 1975-07-03 HU HUSA2816A patent/HU170215B/hu unknown
- 1975-07-04 ZA ZA754304A patent/ZA754304B/en unknown
- 1975-07-04 BE BE158022A patent/BE831042A/en unknown
- 1975-07-04 GB GB28246/75A patent/GB1518683A/en not_active Expired
- 1975-07-04 JP JP50082022A patent/JPS5132724A/ja active Pending
- 1975-07-07 AU AU82801/75A patent/AU8280175A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NZ178011A (en) | 1978-07-28 |
FR2276832B1 (en) | 1978-10-06 |
YU170475A (en) | 1984-02-29 |
SE7507414L (en) | 1976-01-07 |
ZA754304B (en) | 1977-02-23 |
IL47634A (en) | 1978-07-31 |
HU170215B (en) | 1977-04-28 |
BE831042A (en) | 1976-01-05 |
NL7507798A (en) | 1976-01-07 |
ES439113A1 (en) | 1977-10-16 |
FR2276832A1 (en) | 1976-01-30 |
GB1518683A (en) | 1978-07-19 |
DE2528516A1 (en) | 1976-01-22 |
JPS5132724A (en) | 1976-03-19 |
AU8280175A (en) | 1977-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL47634A0 (en) | Pharmaceutical skin permeating preparations | |
ZA741963B (en) | Oral drug preparations | |
ZA735315B (en) | Cosmetic preparations | |
ZA733499B (en) | Hair preparations | |
PH12279A (en) | Biguanide dichlorcacetates and pharmaceutical preparations containing them | |
IL48592A (en) | 1-substituted-4-benzypiperidine derivatives,their preparation and pharmaceutical composistions comprising them | |
ZA751007B (en) | Oral pharmaceutical preparation | |
ZA751102B (en) | Pharmaceutical preparations | |
PH11632A (en) | Hair preparation | |
AU520082B2 (en) | Pharmaceutical preparations | |
IE42324L (en) | Pharmaceutical preparations containing silicone rubber | |
AU4750079A (en) | Pharmaceutical preparations | |
ZA724983B (en) | Pharmaceutical preparations | |
MY7900181A (en) | 1-alkyl-2-(phenoxymethyl)5-nitro-imidazoles and processes for their preparation | |
IL38228A0 (en) | Pharmaceutical preparations containing peptides | |
IL45870A0 (en) | Vaccine preparations | |
ZA755767B (en) | Pharmaceutical preparations | |
ZA731359B (en) | Hair preparations | |
AU7569174A (en) | Pharmaceutical preparations | |
AU5512273A (en) | Medicinal preparations for oral use | |
IL40597A0 (en) | Antihypertensively pharmaceutical preparations | |
ZA745332B (en) | Oral preparations | |
ZA748179B (en) | Ophthlamic preparations | |
ZA755515B (en) | Pharmaceutical formulations | |
AU6654474A (en) | Pharmaceutical preparations |